Expression Levels of MIR-30a-5p in Papillary Thyroid Carcinoma: A Comparison between Serum and Fine Needle Aspiration Biopsy Samples

Genetic Testing and Molecular Biomarkers

Volumn 19, Issue 8, 2015, Pages 418-423

  Igci, Yusuf Ziya ^a   Ozkaya, Mesut ^a   Korkmaz, Hakan ^a   Bozgeyik, Esra ^a   Bayraktar, Recep ^a   Ulasli, Mustafa ^a   Erkilic, Suna ^a   Eraydin, Ayten ^a   Oztuzcu, Serdar ^a  

^a GAZIANTEP UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA; MICRORNA 30A 5P; UNCLASSIFIED DRUG; MIRN30 MICRORNA, HUMAN; TRANSCRIPTOME; TUMOR MARKER;

ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD SAMPLING; CANCER PATIENT; COMPARATIVE STUDY; EVALUATION STUDY; FEMALE; FINE NEEDLE ASPIRATION BIOPSY; HUMAN; HUMAN TISSUE; INVESTIGATIVE PROCEDURES; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; REAL TIME POLYMERASE CHAIN REACTION; THYROID CARCINOMA; THYROID PARAFOLLICULAR CELL; BIOSYNTHESIS; BLOOD; CARCINOMA; GENETICS; MIDDLE AGED; PATHOLOGY; PROCEDURES; PROGNOSIS; THYROID NEOPLASMS;

ADOLESCENT; ADULT; AGED; BIOMARKERS, TUMOR; BIOPSY, FINE-NEEDLE; CARCINOMA; FEMALE; HUMANS; MALE; MICRORNAS; MIDDLE AGED; PROGNOSIS; THYROID NEOPLASMS; TRANSCRIPTOME;

EID: 84938320428     PISSN: 19450265     EISSN: 19450257     Source Type: Journal    
DOI: 10.1089/gtmb.2015.0062     Document Type: Article

References (31)

1. Baraniskin A, Birkenkamp-Demtroder K, Maghnouj A, et al. (2012) MiR-30a-5p suppresses tumor growth in colon carcinoma by targeting DTL. Carcinogenesis 33: 732-739.
2. Calin GA, Croce CM (2006) MicroRNA-cancer connection: The beginning of a new tale. Cancer Res 66: 7390-7394.
3. Calin GA, Sevignani C, Dumitru CD, et al. (2004) Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc Natl Acad Sci U S A 101: 2999-3004.
4. Carcangiu M, Bianchi S, Savino D, et al. (1991) Follicular Hurthle cell tumors of the thyroid gland. Cancer 68: 1944-1953.
5. Dettmer M, Perren A, Moch H, et al. (2013) Comprehensive microRNA expression profiling identifies novel markers in follicular variant of papillary thyroid carcinoma. Thyroid 23: 1383-1389.
6. Faquin WC (2009) Diagnosis and reporting of follicular-patterned thyroid lesions by fine needle aspiration. Head Neck Pathol 3: 82-85.
7. Gregory RI, Shiekhattar R (2005) MicroRNA biogenesis and cancer. Cancer Res 65: 3509-3512.
8. He H, Jazdzewski K, Li W, et al. (2005) The role of microRNA genes in papillary thyroid carcinoma. Proc Natl Acad Sci U S A 102: 19075-19080.
9. Igci YZ, Arslan A, Akarsu E, et al. (2011) Differential expression of a set of genes in follicular and classic variants of papillary thyroid carcinoma. Endocr Pathol 22: 86-96.
10. Igci YZ, Erkilic S, Arslan A (2014) Septin 7 immunoexpression in papillary thyroid carcinoma: A preliminary study. Pathol Res Pract 210: 426-431.
11. Jansson MD, Lund AH (2012) MicroRNA and cancer. Mol Oncol 6: 590-610.
12. Jia Z, Wang K, Wang G, et al. (2013) MiR-30a-5p antisense oligonucleotide suppresses glioma cell growth by targeting SEPT7. PLoS One 8: e55008.
13. Kong YW, Ferland-McCollough D, Jackson TJ, et al. (2012) MicroRNAs in cancer management. Lancet Oncol 13: e249-e258.
14. Lee JC, Gundara JS, Glover A, et al. (2014) MicroRNA expression profiles in the management of papillary thyroid cancer. Oncol 19: 1141-1147.
15. Leonardi GC, Candido S, Carbone M, et al. (2012) microRNAs and thyroid cancer: biological and clinical significance (Review) . Int J Mol Med 30: 991.
16. Li X, Abdel-Mageed AB, Mondal D, et al. (2013) MicroRNA expression profiles in differentiated thyroid cancer, a review. Int J Clin Exp Med 6: 74.
17. Lundstrom K (2011) Micro-RNA in disease and gene therapy. Curr Drug Discov Technol 8: 76-86.
18. McManus MT (2003) MicroRNAs and cancer. Semin Cancer Biol 13: 253-258.
19. Nikiforov YE, Ohori NP, Hodak SP, et al. (2011) Impact of mutational testing on the diagnosis and management of patients with cytologically indeterminate thyroid nodules: A prospective analysis of 1056 FNA samples. J Clin Endocrinol Metab 96: 3390-3397.
20. Nikiforova MN, Tseng GC, Steward D, et al. (2008) MicroRNA expression profiling of thyroid tumors: biological significance and diagnostic utility. J Clin Endocrinol Metab 93: 1600-1608.
21. Pallante P, Visone R, Ferracin M, et al. (2006) MicroRNA deregulation in human thyroid papillary carcinomas. Endocr Relat Cancer 13: 497-508.
22. Saez JMG (2011) Diagnostic and prognostic markers in differentiated thyroid cancer. Curr Genomics 12: 597.
23. Schwertheim S, Sheu SY, Worm K, et al. (2009) Analysis of deregulated miRNAs is helpful to distinguish poorly differentiated thyroid carcinoma from papillary thyroid carcinoma. Horm Metab Res 41: 475-481.
24. Shibru D, Chung K-W, Kebebew E (2008) Recent developments in the clinical application of thyroid cancer biomarkers. Curr Opin Oncol 20: 13-18.
25. Soifer HS, Rossi JJ, Satrom P (2007) MicroRNAs in disease and potential therapeutic applications. Mol Ther 15: 2070-2079.
26. Tetzlaff MT, Liu A, Xu X, et al. (2007) Differential expression of miRNAs in papillary thyroid carcinoma compared to multinodular goiter using formalin fixed paraffin embedded tissues. Endocr Pathol 18: 163-173.
27. Torres A, Torres K, Pesci A, et al. (2013) Diagnostic and prognostic significance of miRNA signatures in tissues and plasma of endometrioid endometrial carcinoma patients. Int J Cancer 132: 1633-1645.
28. Tsukamoto O, Miura K, Mishima H, et al. (2014) Identification of endometrioid endometrial carcinoma-associated microRNAs in tissue and plasma. Gynecol Oncol 132: 715-721.
29. Visone R, Pallante P, Vecchione A, et al. (2007) Specific microRNAs are downregulated in human thyroid anaplastic carcinomas. Oncogene 26: 7590-7595.
30. Wilson C (2010) Cancer: microRNA expression provides clues about the aggressiveness of papillary thyroid carcinoma. Nat Rev Endocrinol 6: 416-416.
31. Yuan Z-m, Yang Z-l, Zheng Q (2014) Deregulation of micro-RNA expression in thyroid tumors. J Zhejiang Univ Sci B 15: 212-224.